CD22 and hemolytic-uremic syndrome: While CLS is a common effect of immunotoxins targeting a variety of antigens [55,56,117,118,119,120,121,122,123], HUS has only been reported from those targeting CD22 [57,58,59,60,64,65,80,81,124,125,126].